Listen to this articleBelow is our recent interview with Jassi Chadha, CEO & President of Axtria:
Q: Could you provide our readers with a brief introduction to your company?
A: Axtria is a global provider of award-winning cloud software and data analytics to the Life Sciences industry. Axtria’s solutions are used to digitally transform the entire product commercialization process, drive sales growth, and improve healthcare outcomes for patients. Our focus is on delivering solutions that help customers complete the journey from Data-to-Insights-to-Action and get superior returns from their sales and marketing investments.
Axtria supports more than 100 life sciences companies, including 12 of the top 20 global leaders with its cutting-edge software solutions. The company has been recognized for its growth in the Inc. 5000, Deloitte Technology Fast 500™, NJBIZ Fast 50, SmartCEO Future 50 and Red Herring 100 rankings.
Q: Any highlights on your recent announcement?
A: With this significant funding, we are doubling down on our commitment to make the industry future-ready with record investments in our SaaS products. AI and Machine Learning driven advanced analytics will be embedded across all levels allowing companies to engage their customers through omnichannel strategies. The funding will enable Axtria to consolidate its strong position in cloud software and artificial intelligence (AI) by rapidly expanding its suite of life sciences focused SaaS platforms.
Recommended: An Interview With Benjamín Labr, CEO & Co-Founder Of Houm
Q: Can you give us more insights into your offering?
A: With the life sciences and healthcare industry undergoing a significant acceleration in data-driven digital transformation, there is a strong push to leverage software technology and AI to effectively scale global commercial operations. The crisis created by the COVID-19 pandemic further accelerated this need. More than ever, companies are looking to replace archaic and ad hoc systems with digital data enablement, analytics at scale, and omnichannel software to deliver improved customer experience. Serving this impending need, Axtria has emerged as a disruptive and innovative leader with a robust suite of AI-powered platforms – Axtria DataMAx for data management, Axtria InsightsMAx for analytics, and Axtria SalesIQ and Axtria CustomerIQ for omnichannel commercial operations.
Q: What can we expect from your company in next 6 months? What are your plans?
A: The industry is no longer only looking for consultants and custom-built solutions but for partners that will help them bring therapeutic drugs to market faster and efficiently. Over the years, we have made significant investments to develop life sciences-focused software platforms that significantly improve strategic and day-to-day global operations. With this new investment, Axtria will further solidify its leadership position of enterprise products that help customers drive better patient outcomes globally.
Recommended: Cardea Develops A Tech+Bio Infrastructure Based On Proprietary Biology-Gated Transistors, Or Cardean Transistors
Q: What is a great thing about your company that people might not know about?
A: We are a people-first organization that genuinely care about each other as global team. Because of our culture, we can respond and perform even under the most challenging circumstances. When the COVID pandemic devastated our colleagues and their families in India, Axtria quickly mobilized a crowdfunding campaign that has raised more than $175,000 to -date to help India and its people through this difficult period, and matched every employee contribution 1:1. Colleagues across the company stepped up to support and offer whatever was necessary to see projects and engagements successfully to their completion at an exceptional level of performance for our clients. We passionately believe in the work of our clients and will collaborate and bring to bear our collective experience, expertise and knowledge to find answers to their most perplexing questions.
